Senti Biosciences, Inc. (SNTI)
Data as of , from SEC Form 4 filings.
See up to 3 months of SNTI. The 7-day demo opens the 1M and 3M ranges and puts SNTI on your watchlist.
Start 7-day demoLatest SNTI insider trades
About Senti Biosciences, Inc. (SNTI)
Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).
- SOUTH SAN FRANCISCO, CA
- 39
- 2022
- XNAS
SNTI Form 4 activity by transaction type, last 90 days
No Form 4 activity for SNTI in the last 90 days.
SNTI insider transactions (Form 4)
119 Form 4 filings on record, the earliest from Dec 10, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Kanya Rajangam - Officer | Tax withholding / forfeiture | Common Stock | 10,757 footnote F1 | $0.00 | - | |
| ||||||
 Timothy K. Lu - Officer | Tax withholding / forfeiture | Common Stock | 80,666 footnote F1 | $0.00 | - | |
| ||||||
| Kanya Rajangam - Officer | Tax withholding / forfeiture | Common Stock | 1,384 footnote F1 | $0.00 | - | |
| ||||||
| Timothy K. Lu - Officer | Tax withholding / forfeiture | Common Stock | 4,191 footnote F1 | $0.00 | - | |
| ||||||
| Bryan Daniel Baum - Director | Grant or award | Stock Option (Right to Buy) | 43,900 | $0.00 | - | |
| BAYER HEALTHCARE LLC - 10% Owner | Open-market purchase | Series A Convertible Preferred Stock | 2,222 | - | - | |
| BAYER HEALTHCARE LLC - 10% Owner | Open-market purchase | Warrant | 3,333,000 | - | - | |
| Fran Schulz - Director | Grant or award | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
 Donald F. Tang - Director | Grant or award | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| Kanya Rajangam - Officer | Grant or award | Series A Convertible Preferred Stock | 33 | $2,250.00 | $74K | |
| Kanya Rajangam - Officer | Grant or award | Common Stock Warrant (right to buy) | 49,500 | $0.00 | - | |
SNTI insider trading FAQ
What is the latest insider trade for SNTI?
Senti Biosciences, Inc. (SNTI) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-03-11. The full record for SNTI runs to 9 Form 4 filings, the earliest from 2024-12-10. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SNTI stock?
No insider purchases of SNTI were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling SNTI stock?
No insider sales of SNTI were filed in the last 90 days.
Where can I see SNTI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SNTI Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
9The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Kanya Rajangam view on EDGAR
- - Timothy K. Lu view on EDGAR
- - Kanya Rajangam view on EDGAR
- - Timothy K. Lu view on EDGAR
- - Bryan Daniel Baum view on EDGAR
- - BAYER HEALTHCARE LLC view on EDGAR
- - Fran Schulz view on EDGAR
- - Donald F. Tang view on EDGAR
- - Kanya Rajangam view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where SNTI's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SNTI with a 7-day demo
- SNTI on your watchlist
- Every SNTI Form 4 filing on record
- Up to 3 months of SNTI price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
